We found that there were significant radioactive signals in the T2, T3, and T4 tumors compared to the control, T1 (Figure 5A), revealing that CD8+ T cells have the migratory capacity for homing to tumor cells no matter whether co-injected with A549 or not (Figure 5B). Here, CD8A is linked to neoplasm.